highly significantP value < .001
The first subgroup analysis examined trials with fractures being prespecified as a primary endpoint, and the second focused on the highly significant results with a P value < .001.
The first subgroup analysis examined trials with fractures being prespecified as a primary endpoint, and the second focused on the highly significant results with a P value < .001.